ESC Professional Premium Access

Effect of dronedarone versus placebo on atrial fibrillation progression: a post-hoc analysis from ATHENA trial

Congress Presentation

About the speaker

Professor Carina Blomstrom-Lundqvist

Orebro University Hospital, Orebro (Sweden)
37 presentations

5 more presentations in this session

Association between early rhythm control and the risk of dementia in patients with atrial fibrillation and prior history of stroke: a nationwide population-based study

Speaker: Doctor S. Lee (Seoul, KR)


Dronedarone versus sotalol in patients with atrial fibrillation: a systematic literature review and network meta-analysis

Speaker: Professor J. Camm (London, GB)


Holistic approach of ablation versus antiarrhythmic drugs for efficacy, safety, and quality of life improvement in rhythm control of atrial fibrillation: a meta-analysis of randomized trials

Speaker: Mr G. Prana Jagannatha (Denpasar, ID)


Sex differences in the use of rhythm control strategies in patients with atrial fibrillation in FinACAF study

Speaker: Ms K. Kalatsova (Helsinki, FI)


Prevalence of modifiable risk factors and related poor cardiovascular outcomes following atrial fibrillation ablation

Speaker: Doctor K. Stout (Omaha, US)


Access the full session

Atrial fibrillation: rate or rhythm control

Speakers: Professor C. Blomstrom-Lundqvist, Doctor S. Lee, Professor J. Camm, Mr G. Prana Jagannatha, Ms K. Kalatsova...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb